As is well-known, signet ring cell carcinoma (SRCC) rarely appears as a histological finding in the prostatic tissue. Nevertheless, a differentiation should be made between a primary tumor and a metastatic disease. We describe the case of a 52-year-old man with lower urinary tract symptoms, serum total PSA of 0.2 ng/ml, elevated serum CEA and CA19-9 levels. Two years prior to presentation, he underwent total gastrectomy with histological findings indicating "poor differentiated adenocarcinoma with signetring cell". A palpable nodule was found on digital rectal examination and for this reason he underwent 12-core transperineal prostate biopsy with a diagnosis of "poor differentiated adenocarcinoma with signet-ring cell and adipose tissue infiltration". Immunohistochemical examinations revealed positivity for PAS, CK7 and CDX-2, focal positivity for CK20 and negativity for PSA and PSAP. The diagnosis of a prostatic secondary SRCC was possible given the positivity to CK7, CDX-2, focal positivity to CK20 and negativity to PSA.
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As is well-known, signet ring cell carcinoma (SRCC) rarely appears as a histological finding in the prostatic tissue. Nevertheless, a differentiation should be made between a primary tumor and a metastatic disease. We describe the case of a 52-year-old man with lower urinary tract symptoms, serum total PSA of 0.2 ng/ml, elevated serum CEA and CA19-9 levels. Two years prior to presentation, he underwent total gastrectomy with histological findings indicating "poor differentiated adenocarcinoma with signetring cell". A palpable nodule was found on digital rectal examination and for this reason he underwent 12-core transperineal prostate biopsy with a diagnosis of "poor differentiated adenocarcinoma with signet-ring cell and adipose tissue infiltration". Immunohistochemical examinations revealed positivity for PAS, CK7 and CDX-2, focal positivity for CK20 and negativity for PSA and PSAP. The diagnosis of a prostatic secondary SRCC was possible given the positivity to CK7, CDX-2, focal positivity to CK20 and negativity to PSA.
As is well-known, a Krukenberg tumor is an ovarian-metastasis, usually originating in the stomach in female patients and characterized by the presence of signet-ring cells. Although SRCC (signet-ring cell carcinoma) is primarily found in the stomach and colon, it can also be found in the pancreas, breast, thyroid, bladder and prostate (1) .
Gastric adenocarcinoma can be sub-typified into two major groups: the intestinal type and the diffuse type, in accordance with Lauren's classification. The diffuse type is identified by the presence of signetring cells, with intracytoplasmatic vacuoles ofmucin. Despite the particular gastrointestinal localization of the SRCC, it can occur in 2.5% of adenocarcinomas of the prostate but, in any event, it is necessary to differentiate a primary tumor of the prostate from a metastatic disease (2) .
Because SRCCs from other peritoneal organs (such as the bladder, ovary, uterus and prostate) are uncommon, most cases of intra-abdominal and intralymphatic SRCCs are metastases from the stomach, breast, or colon (3). Using immunohistochemistry, by means ofCD7, CD20 and CDX-2, in addition to PSA and PSAP, a prostatic SRCC can be differentiated from a metastatic prostatic SRCC (4).
We report the rare case of a gastric signet-ring cell metastasized to the prostate of a 52-year-old male patient. suffered from lower urinary tract symptoms for about one year, with a serum total PSA of 0.2 ng/ml and elevated serum CEA and CA19-9 levels. Urinalysis and bacterial culture were negative for infection. Two years previous to presentation, he had undergone a total gastrectomy with histological findings indicating "poor differentiated adenocarcinoma with signet-ring cells, infiltrating the gastric wall into the subserosa and with metastasis to the perigastric lymph node, pT2bN3Mx G3-4".
On digital rectal examination, a palpable nodule was found on the right lobe and for this reason he underwent a 12-core transperineal prostatic biopsy.
Immunohistochemistry
Prostatic tissue was fixed in 10% neutral formalin and embedded in paraffin. 5-llm thick slides were stained with hematoxylin-eosin and periodic acid-Schiff (PAS). Immunohistochemical staining positivity was evaluated using avidinbiotin-peroxidase with the following monoclonal antibodies: CK7 (clone OV-TL 12/30; Dako Corp., Carpinteria, CA, USA. Dilution 1:800), CK20 (clone Ks 20.8; Dako Corp. Dilution 1:200), PSA and CDX-2 (clone EPR2764Y, Ventana Medical System, Ready-to-use). Image acquisition was performed using a Leica DM6000B light microscope (Leica, Wetzlar, Germany) and the Diskus Mikroskopische Diskussion image acquisition software (Carl H. Hilgers, Konigswinter, Germany). The immunoreactivity was considered positive if cytoplasmic expression of the cytokeratins was observed in at least 1% of the neoplastic cells.
RESULTS
The patient was diagnosed with a poor differentiated adenocarcinoma with signet-ring cells and adipose tissue infiltration (Fig. 1) .
Immunohistochemical examinations revealed positivity for PAS ( Fig. 2) , CK7 and CDX-2 ( Fig. 3) , focal positivity for CK20 and negativity for PSA and PSAP. Cistoscopy and colonscopy were performed in order to exclude bladder or colorectum.
Abdominal and pelvic computed tomography showed a neo-vascularization of the bladder, a prostate adhering to the posterior wall and multiple lymph-node enlargement in the celiac, mesenteric and para-aortic areas (Fig. 4) . Subsequently, the patient was referred for chemotherapy protocol treatment using 5-fluorouracil, cisplatin and epirubicin +radiotherapy for his gastric adenocarcinoma. At the moment of writing the patient is still alive.
DISCUSSION
Although the vast majority ofSRCCs occur in the stomach, breast and colon, in rare cases they can be found in other peritoneal organs (such as the bladder, ovary, uterus and prostate). In cases of a mucinous adenocarcinoma or a signet-ring cell adenocarcinoma locally identified in a prostate biopsy, the main differential diagnosis is the secondary involvement In a study by Chu et aI., including 435 neoplasms , all the cases of prostatic carcinoma were CK7negative, whereas the majority ofcases oftransitional cell carcinoma were CK7-positive. In contrast , only a small percentage ofcases ofadenocarcinoma of the colon (5%) or stomach (28%) were CK7-positi ve. Other neoplasms that were rarely or never CK7positive included prostate adenocarcinoma (0%) (8) . CK20 positivity is seen in the majority of cases of colorectal adenocarcinoma and over one-third of cases of gastric adenocarcinoma (8) .
In a case report and review, Kuroda et aI. demonstrated that gastric SRCCs showed a positive reaction in the tumor cell cytoplasm for CK7 and CK20. In particular, CK20 and CK7 were strongly positive in the cytoplasm of signet ring cells (9) .
The co-expression of CK7 and CK20 largely . excludes a metastatis from a colorectal adenocarcinoma, but will not necessarily ;exclude metastases from gastric, oesophageal or pancreatobiliary primaries (10) . In the absence of results from other markers, the demonstration of CK7 positivity alone has limited value in the differential diagnosis of metastatic carcinoma (11) . Indeed, the different histological patterns of CK7, CK20 and CDX-2 are crucial in diagnosing a tumor of unknown origin.
Analyzing lesions from 105 patients, Kende et aI. found the great majority of adenocarcinomas of the upper gastrointestinal tract to express both CK7 and CK20, while a CK7-/CK20+ pattern was reported in the large intestine (12) . CDX-2 is a homebox nuclear transcription factor, that regulates cell proliferation and differentiation of the intestinal epithelium and is involved in the pathogenesis of gastrointestinal tumors.
High levels ofCDX2 expressionwere foundalmost exclusively in adenocarcinomas of the colorectum, and intermediate levels of immunostaining were found in many adenocarcinomas arising elsewhere in the GI tract. Moshaluk et al revealed extensive nuclear staining (>50% of cells) for CDX2 in colorectal adenocarcinomas (90%) (13) . In a study by Werling et al, CDX2 expression alone does not reliably distingui sh colorectal adenocarcinomas from adenocarcinomas arising elsewhere in the GI tract, particularly pancreatic and gastric adenocarcinomas, although the sensitivity of CDX2 for intestinal tumors is significantly higher (99%) of the prostate from a rectal primary (5) . In these rare cases, immunohistochemical examination is useful to determine the primary tumor (6, 7) . Although theexpressionofcytokeratins isgenerally confined to the epithelia and their neoplasm, it is difficult to arrive at a specific diagnosis . The diverse, unique expression of CK7 and CK20 in carcinomas has been found to be important in determining the site of origin of many adenocarcinomas (8) . In fact, the use of a combination of CK7 and CK20, in addition to PSA and PSAP, may be decisive in differentiating a prostatic SRCC from a gastrointestinal SRCC (9) . CK7 seems to be extremely useful when the differential diagnosis between a prostatic carcinoma and a transitional cell carcinoma of the prostate or other genitourinary organs is at issue. than for the latter type (67%) (14) .
In many cases the origin of the primary tumor is difficult to establish, but in our case the diagnosis of a prostatic secondary SRCC was possible through positivity to CK7, CDX-2, focal positivity to CK20 and negativity to PSA.
In conclusion, signet-ring cell carcinoma is a rare histological finding in prostate cancer and it is necessary to differentiate a primary tumor from a metastatic disease. For these reasons, immunohistochemistry by means ofCK7, CK20 and CDX-2 seems to be useful in diagnosing the primary site of the tumor.
